Exosite  has licensed its IIoT software technology and solutions to West Pharmaceutical Services, a global leader in innovative solutions for injectable drug administration. West Pharmaceutical will use Exosite’s IoT technology to support and accelerate its digital transformation initiatives. The two organisations are also set collaborate on a Digital Technology Center that West Pharmaceutical is set to open  in Taiwan this month.
"We are very pleased to see Exosite technologies deployed broadly across the healthcare marketplace," said Hans Rempel, CEO, Exosite. "I'm confident that our mature technologies will contribute significantly to West's digital transformation initiatives, and I look forward to the collaboration between our organizations in the coming years."
Going forward, Exosite will provide support for West’s Digital Technology Center and other regional customers through its teams in both Taiwan and Minneapolis. As an organisation, Exosite will continue to expand its zero-barrier IIoT applications, like ExoSense and ExoHome, and its off-the-shelf vertical solutions offering best-in-class features that enable organisations to quickly deploy connected solutions.
Exosite has been working with the world’s leading manufacturers with IoT technology and solutions that accelerate connected-product development and support a digital strategy for long-term success.
Exosite’s technologies have been validated in highly regulated markets similar to West Pharmaceutical’s and deployed in a variety of public and private cloud environments. These proven technologies help companies like West Pharmaceutical provide new value to customers and stakeholders through digital monitoring and innovation.
